Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2006 September; 7(3): E74–E79.
Published online 2006 August 4. doi:  10.1208/pt070366
PMCID: PMC2750508

Chitosan lactate as a nonviral gene delivery vector in COS-1 cells


The purpose of this research was to evaluate chitosan lactate (CL) of different molecular weights (MWs) as a DNA complexing agent for its efficiency in transfecting COS-1 cells (green monkey fibroblasts) and its effect on cell viability compared with polyethylenimine (PEI), a commercially available cationic polymer. CL and chitosan base dissolved in dilute acetic acid (chitosan acetate, [CA]) of different MWs (20, 45, 200, 460 kDa) and N/P ratios (2[ratio]1, 4[ratio]1, 8[ratio]1, 12[ratio]1, 24[ratio]1) formed complexes with pSV β-galactosidase plasmid DNA. The complexes were characterized by agarose gel electrophoresis and investigated for their ability to transfect COS-1 cells compared with PEI. Additionally, the effect of CL on the viability of COS-1 cells was investigated using 3-(4,5-dimethyliazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The binding of CL/DNA and CA/DNA was dependent on chitosan MWs. The N/P ratio of CL to completely form the complex with the DNA was higher than that of CA. Both CL and CA were comparable in transfection efficiencies at an N/P ratio of 12[ratio]1, but less efficient than PEI (P<.05). The cell viability in the presence of CL and CA at all MWs was over 90%, whereas that of PEI-treated cells was ≈50%. These results suggest the advantage of CL for in vitro gene transfection, with the ease of preparation of polymer/DNA complexes and low cytotoxicity.

Keywords: chitosan, chitosan lactate, transfection efficiency, gene delivery, COS-1 cells

Full Text

The Full Text of this article is available as a PDF (168K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000;17:113–126. doi: 10.1023/A:1007548826495. [PubMed] [Cross Ref]
2. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 2003;21:117–122. doi: 10.1016/S0167-7799(02)00042-2. [PubMed] [Cross Ref]
3. Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem. 1994;269:2550–2561. [PubMed]
4. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995;1235:289–295. doi: 10.1016/0005-2736(95)80016-9. [PubMed] [Cross Ref]
5. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 1995;270:18997–19007. doi: 10.1074/jbc.270.32.18997. [PubMed] [Cross Ref]
6. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release. 1998;51:213–220. doi: 10.1016/S0168-3659(97)00173-9. [PubMed] [Cross Ref]
7. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 2004;57:1–8. doi: 10.1016/S0939-6411(03)00155-3. [PubMed] [Cross Ref]
8. Maclaughlin FC, Mumper RJ, Wang J, et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release. 1998;56:259–272. doi: 10.1016/S0168-3659(98)00097-2. [PubMed] [Cross Ref]
9. Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization. J Control Release. 2001;75:409–419. doi: 10.1016/S0168-3659(01)00407-2. [PubMed] [Cross Ref]
10. Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001;51:81–96. doi: 10.1016/S0169-409X(01)00171-5. [PubMed] [Cross Ref]
11. Kim TH, Kim SI, Akaike T, Cho CS. Synergistic effect of poly (ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release. 2005;105:354–366. doi: 10.1016/j.jconrel.2005.03.024. [PubMed] [Cross Ref]
12. Corsi K, Chellat F, Yahia L, Fernandes JC. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials. 2003;24:1255–1264. doi: 10.1016/S0142-9612(02)00507-0. [PubMed] [Cross Ref]
13. Wan LQ, Hu FQ, Yuan H. Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells. Yao Xue Bao. 2004;39:227–231. [PubMed]
14. Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials. 2001;22:2075–2080. doi: 10.1016/S0142-9612(00)00385-9. [PubMed] [Cross Ref]
15. Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm. 2002;53:57–63. doi: 10.1016/S0939-6411(01)00198-9. [PubMed] [Cross Ref]
16. Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials. 2002;23:153–159. doi: 10.1016/S0142-9612(01)00090-4. [PubMed] [Cross Ref]
17. Dastan T, Turan K. In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells. J Pharm Pharm Sci. 2004;7:205–214. [PubMed]
18. Mao H-Q, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70:399–421. doi: 10.1016/S0168-3659(00)00361-8. [PubMed] [Cross Ref]
19. Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 2001;1514:51–64. doi: 10.1016/S0005-2736(01)00362-5. [PubMed] [Cross Ref]
20. Kiang T, Wen J, Lim HW, Leong KW. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials. 2004;25:5293–5301. doi: 10.1016/j.biomaterials.2003.12.036. [PubMed] [Cross Ref]
21. Carreño-Gómez B, Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microsphere. Int J Pharm. 1997;148:231–240. doi: 10.1016/S0378-5173(96)04847-8. [Cross Ref]
22. Nunthanid J, Laungtana-anan M, Sriamornsak P, et al. Characterization of chitosan acetate as a binder for sustained release tablets. J Control Release. 2004;99:15–26. doi: 10.1016/j.jconrel.2004.06.008. [PubMed] [Cross Ref]
23. Davis LG, Kuehl WM, Battey JF. Basic Methods in Molecular Biology. Norwalk, CT: Appleton & Lange; 1994. pp. 249–253.
24. Mao S, Shuai X, Unger F, Simon M, Bi D, Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm. 2004;281:45–54. doi: 10.1016/j.ijpharm.2004.05.019. [PubMed] [Cross Ref]
25. Lee KY, Kwon IC, Jo WH, Jeong SY. Complex formation between plasmid DNA and self-aggregates of deoxycholic acid-modified chitosan. Polymer. 2005;46:8107–8112. doi: 10.1016/j.polymer.2005.06.082. [Cross Ref]
26. Huang M, Fong C-W, Khor E, Lim L-Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Control Release. 2005;106:391–406. doi: 10.1016/j.jconrel.2005.05.004. [PubMed] [Cross Ref]
27. Richardson SC, Kolbe HV, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm. 1999;178:231–243. doi: 10.1016/S0378-5173(98)00378-0. [PubMed] [Cross Ref]
28. Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors: synthesis, cytotoxicity and transfection efficiency in epithelial cell lines. Biomaterials. 2002;23:153–159. doi: 10.1016/S0142-9612(01)00090-4. [PubMed] [Cross Ref]
29. Florea BI, Meaney C, Junginger HE, Borchard G. Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS Pharm. Sci. 2002;4:E12–E12. doi: 10.1208/ps040312. [PMC free article] [PubMed] [Cross Ref]
30. Kim TH, Park IK, Nah JW, Choi YJ, Cho CS. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials. 2004;25:3783–3792. doi: 10.1016/j.biomaterials.2003.10.063. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists